These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

512 related items for PubMed ID: 7522957

  • 1. Identification of MART-1-specific T-cell receptors: T cells utilizing distinct T-cell receptor variable and joining regions recognize the same tumor epitope.
    Cole DJ, Weil DP, Shamamian P, Rivoltini L, Kawakami Y, Topalian S, Jennings C, Eliyahu S, Rosenberg SA, Nishimura MI.
    Cancer Res; 1994 Oct 15; 54(20):5265-8. PubMed ID: 7522957
    [Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3. T-cell receptor repertoire in matched MART-1 peptide-stimulated peripheral blood lymphocytes and tumor-infiltrating lymphocytes.
    Cole DJ, Wilson MC, Rivoltini L, Custer M, Nishimura MI.
    Cancer Res; 1997 Dec 01; 57(23):5320-7. PubMed ID: 9393756
    [Abstract] [Full Text] [Related]

  • 4. Cytolytic T-cell clones define HLA-A2-restricted human cutaneous melanoma peptide epitopes: correlation with T-cell receptor usage.
    Maeurer MJ, Hurd S, Martin DM, Storkus WJ, Lotze MT.
    Cancer J Sci Am; 1995 Dec 01; 1(2):162-70. PubMed ID: 9166469
    [Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Dual recognition of a human cytotoxic T-cell clone for melanoma antigens.
    Kubo H, Abe J, Obata F, Nakajima H, Tsunoda M, Ogawa A, Nakayama S, Beck Y, Kohsaka T, Darrow TL, Abdel-Wahab Z, Saida T, Takiguchi M.
    Cancer Res; 1996 May 15; 56(10):2368-74. PubMed ID: 8625313
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. T cell receptor (TCR) structure of autologous melanoma-reactive cytotoxic T lymphocyte (CTL) clones: tumor-infiltrating lymphocytes overexpress in vivo the TCR beta chain sequence used by an HLA-A2-restricted and melanocyte-lineage-specific CTL clone.
    Sensi M, Salvi S, Castelli C, Maccalli C, Mazzocchi A, Mortarini R, Nicolini G, Herlyn M, Parmiani G, Anichini A.
    J Exp Med; 1993 Oct 01; 178(4):1231-46. PubMed ID: 8376931
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Induction of tumor-reactive CTL from peripheral blood and tumor-infiltrating lymphocytes of melanoma patients by in vitro stimulation with an immunodominant peptide of the human melanoma antigen MART-1.
    Rivoltini L, Kawakami Y, Sakaguchi K, Southwood S, Sette A, Robbins PF, Marincola FM, Salgaller ML, Yannelli JR, Appella E.
    J Immunol; 1995 Mar 01; 154(5):2257-65. PubMed ID: 7868898
    [Abstract] [Full Text] [Related]

  • 11. Recognition of shared melanoma antigen by HLA-A2-restricted cytolytic T cell clones derived from human tumor-infiltrating lymphocytes.
    Viret C, Davodeau F, Guilloux Y, Bignon JD, Semana G, Breathnach R, Jotereau F.
    Eur J Immunol; 1993 Jan 01; 23(1):141-6. PubMed ID: 8419164
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. A self-reactive class I-restricted T-cell response of H-2b mice to determinants of the V beta 8.2 domain of the T-cell receptor for antigen.
    Kuhröber A, Schirmbeck R, Reimann J.
    Immunology; 1994 Dec 01; 83(4):532-9. PubMed ID: 7533132
    [Abstract] [Full Text] [Related]

  • 14. Shared amino acid sequences in the ND beta N and N alpha regions of the T cell receptors of tumor-infiltrating lymphocytes within malignant glioma.
    Ebato M, Nitta T, Yagita H, Sato K, Okumura K.
    Eur J Immunol; 1994 Dec 01; 24(12):2987-92. PubMed ID: 7805726
    [Abstract] [Full Text] [Related]

  • 15. TCR beta-chain variable region-driven selection and massive expansion of HLA-class I-restricted antitumor CTL lines from HLA-A*0201+ melanoma patients.
    Maccalli C, Farina C, Sensi M, Parmiani G, Anichini A.
    J Immunol; 1997 Jun 15; 158(12):5902-13. PubMed ID: 9190943
    [Abstract] [Full Text] [Related]

  • 16. Diversity and dominance among TCR recognizing HLA-A2.1+ influenza matrix peptide in human MHC class I transgenic mice.
    Man S, Ridge JP, Engelhard VH.
    J Immunol; 1994 Nov 15; 153(10):4458-67. PubMed ID: 7963521
    [Abstract] [Full Text] [Related]

  • 17. Cytolytic T lymphocyte recognition of the immunodominant HLA-A*0201-restricted Melan-A/MART-1 antigenic peptide in melanoma.
    Romero P, Gervois N, Schneider J, Escobar P, Valmori D, Pannetier C, Steinle A, Wolfel T, Lienard D, Brichard V, van Pel A, Jotereau F, Cerottini JC.
    J Immunol; 1997 Sep 01; 159(5):2366-74. PubMed ID: 9278327
    [Abstract] [Full Text] [Related]

  • 18. Biased T cell receptor usage by Ld-restricted, tum- peptide-specific cytotoxic T lymphocyte clones.
    Solheim JC, Alexander-Miller MA, Martinko JM, Connolly JM.
    J Immunol; 1993 Feb 01; 150(3):800-11. PubMed ID: 8380825
    [Abstract] [Full Text] [Related]

  • 19. Human renal cell carcinoma antigen-specific CTLs: antigen-driven selection and long-term persistence in vivo.
    Jantzer P, Schendel DJ.
    Cancer Res; 1998 Jul 15; 58(14):3078-86. PubMed ID: 9679974
    [Abstract] [Full Text] [Related]

  • 20. Tumor-specific and HLA-A2-restricted cytolysis by tumor-associated lymphocytes in human metastatic breast cancer.
    Linehan DC, Goedegebuure PS, Peoples GE, Rogers SO, Eberlein TJ.
    J Immunol; 1995 Nov 01; 155(9):4486-91. PubMed ID: 7594611
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 26.